Abstract
Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have